Evolution of the Average Target: Legence Corp.

Evolution of the Average Target - Legence Corp.

Evolution of the Target Price: Legence Corp.

Evolution of the Target Price - Legence Corp.

Changes in Analyst Recommendations: Legence Corp.

ae4948933fc4d7a5f61857cef054.O_HqlFy6FZxb0wlYQQY47J7vFpTOX8ZMNcMvY8vb5Qo.XIme0G72SvlonGoHHm9N3PaHYdWbcpAZepoYGqGUr0J6v4fjMIpn_R_rbg~4e5c34306d5b036a136bf46d25c15ce6
10-15 RBC Cuts Price Target on Legence to $90 From $101, Keeps Outperform Rating MT
08-19 Tigress Financial Adjusts Price Target on Legence to $130 From $125, Keeps Buy Rating MT
08-14 BofA Securities Adjusts Legence Price Target to $116 From $105 MT
07-22 RBC Trims Price Target on Legence to $101 From $106, Keeps Outperform Rating MT
05-19 Tigress Adjusts Price Target on Legence to $125 From $85, Maintains Buy Rating MT
04-29 Loop Capital Initiates Legence Corp at Buy MT
04-16 Tigress Adjusts Price Target on Legence to $85 From $60, Maintains Buy Rating MT
01-22 Tigress Financial Adjusts Legence Price Target to $60 From $54, Maintains Buy Rating MT
11-21 Tigress Financial Initiates Legence at Buy With $54 Price Target MT
11-18 Legence Shares Rise After Upgrade From Jefferies MT
11-18 Jefferies Upgrades Legence Corp to Buy From Hold, Adjusts Price Target to $49 From $39 MT
11-17 RBC Raises Price Target on Legence to $48 From $36, Keeps Outperform Rating MT
25-10-24 Roth Capital Initiates Legence Corp at Buy With $41 Price Target MT
25-10-07 BMO Capital Initiates Coverage on Legence With Outperform Rating, $36 Price Target MT
25-10-07 Goldman Sachs Initiates Coverage on Legence With Buy Rating, $37 Price Target MT
25-10-07 Jefferies & Co Initiates Coverage on Legence With Hold Rating, $34 Price Target MT
25-10-07 Stifel Nicolaus Initiates Coverage on Legence With Buy Rating, $36 Price Target MT
25-10-07 Rothschild & Co Redburn Initiates Coverage on Legence With Buy Rating, $35.50 Price Target MT
25-10-07 Barclays Initiates Coverage on Legence With Equal Weight Rating, $34 Price Target MT
25-10-07 BTIG Research Initiates Coverage on Legence With Buy Rating, $40 Price Target MT
25-10-07 Wolfe Research Initiates Coverage on Legence With Outperform Rating, $40 Price Target MT
25-10-07 Guggenheim Initiates Coverage on Legence With Buy Rating, $41 Price Target MT
25-10-07 Bernstein Initiates Coverage on Legence With Outperform Rating, $38 Price Target MT
25-10-07 Cantor Fitzgerald Initiates Coverage on Legence With Overweight Rating, $40 Price Target MT
25-10-07 RBC Initiates Legence at Outperform With $36 Price Target MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+106.22%
+28.64%
+21.52%
+9.01%
+7.69%
+62.56%
+26.22%
+34.09%
+18.09%
+41.17%
Average +35.52%
Weighted average by Cap. +26.34%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
35.00USD
Average target price
72.18USD
Spread / Average Target
+106.22%
High Price Target
130.00USD
Spread / Highest target
+271.43%
Low Price Target
50.00USD
Spread / Lowest Target
+42.86%

Analyst Consensus Detail

Analyst consensus - Legence Corp.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Legence Corp.
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Legence Corp.
  1. Stock Market
  2. Stocks
  3. LGN Stock
  4. Consensus Legence Corp.